Syntis Bio, a Boston-based company, is now reportedly developing an innovative daily pill aimed at mimicking the effects of gastric bypass surgery
Syntis Bio, a Boston-based company, is now reportedly developing an innovative daily pill aimed at mimicking the effects of gastric bypass surgery